Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
caught Covid/tested positive too; caught Covid/tested positive too; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): US-MODERNATX-MOC20260116000001 (Moderna). A patient (age and gender not provided) received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in Dec2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Covid-19" (unspecified if ongoing), notes: Had Covid at prior to any Covid, vaccination. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2024, outcome "unknown" and all described as "caught Covid/tested positive too". Clinical course: Patient received first Pfizer covid vaccination in Dec2023. The patient caught Covid in Jan2024. Patient called and stated that "caught Covid/tested positive too". The patient underwent the following laboratory tests and procedures: COVID-19: (Jan2024) Positive. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202600010363 same reporter/drug/event, different patient;
Medical History/Concurrent Conditions: COVID-19 (Had Covid at prior to any Covid vaccination)
Test Date: 202401; Test Name: Covid-19; Result Unstructured Data: Test Result:Positive